Lisa Rarick, MD, former Division Director for FDA CDER, will be Keynote Speaker at PharmaComm 2004, Dec. 1, New York City.

Lisa Rarick, MD will be the keynote speaker for the inaugural PharmaComm conference to be held on Dec. 1 in New York City. Dr. Rarick joins a group of industry thought-leaders and experts at this innovative conference designed to take a realistic look at how the seemingly basic function of creating business-critical regulatory submission documents and communicating with the FDA can present either opportunity or peril.

Salt Lake City, UT; Englewood, NJ (PRWEB) September 29, 2004 --

McCulley/Cuppan and Executive Communications Group announced today that Lisa Rarick, MD will be the keynote speaker for the inaugural PharmaComm conference. Dr. Rarick joins a group of industry thought-leaders and experts at this innovative conference designed to take a realistic look at how the seemingly basic function of creating business-critical regulatory submission documents and communicating with the FDA can present either opportunity or peril.

Dr. Raricks keynote session will provide an insiders privileged insight regarding how drug sponsors can better serve their cause by improving the quality of their written and oral communications with the FDA.

Pharmacomm 2004 will take place Wednesday, December 1, 2004 at the Princeton Club in New York City

PharmaComm 2004 is organized by Executive Communications Group, McCulley/Cuppan, and P.S. Solutions. Participation at this conference will be limited to 60 attendees to ensure the opportunity for open and frank discussions as well as the chance to meet and network with peers. The conference program will cover topics including ensuring quality submission documents, producing positive outcomes from regulatory interactions, and the challenges of improving communication practices within the organization.

Dr. Rarick is an expert in regulatory affairs and reproductive health and has worked as a consultant to the pharmaceutical industry since 2003. Previously she spent fifteen years with FDA where she enjoyed positions from primary reviewer to upper level management in the Center for Drug Evaluation and Research (CDER).

In addition to Dr. Rarick, PharmComm 2004 will feature as principal speakers:

- George Butler, PhD, Global Vice President, Regulatory Affairs, AstraZeneca

- Dave Pizutti, MD, Vice President, Global Pharmacovigilance, Bristol-Myers Squibb

Specific details regarding the PharmaComm 2004 program and other speakers can be found at: www.pharmacomm.info

For additional information contact:

Gregory Cuppan

McCulley/Cuppan LLC

801-685-7717 ext 307

###